Momenta Pharmaceuticals, Inc.
MNTA
MNTA was delisted on the 30th of September, 2020.
133 hedge funds and large institutions have $730M invested in Momenta Pharmaceuticals, Inc. in 2013 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 39 increasing their positions, 48 reducing their positions, and 18 closing their positions.
85% more call options, than puts
Call options by funds: $17.9M | Put options by funds: $9.68M
39% more first-time investments, than exits
New positions opened: 25 | Existing positions closed: 18
23% more capital invested
Capital invested by funds: $591M → $730M (+$139M)
6% more funds holding
Funds holding: 126 → 133 (+7)
19% less repeat investments, than reductions
Existing positions increased: 39 | Existing positions reduced: 48
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VAM
Visium Asset Management
New York
|
+$47.4M |
| 2 |
ACM
Apex Capital Management
Dayton,
Ohio
|
+$10.1M |
| 3 |
PC
PointState Capital
New York
|
+$5.88M |
| 4 |
State of Wisconsin Investment Board
Madison,
Wisconsin
|
+$3.5M |
| 5 |
MAA
Managed Account Advisors
Jersey City,
New Jersey
|
+$2.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BM
Bridger Management
New York
|
-$24M |
| 2 |
DM
Deerfield Management
New York
|
-$14.6M |
| 3 |
State Street
Boston,
Massachusetts
|
-$8.02M |
| 4 |
Goldman Sachs
New York
|
-$4.47M |
| 5 |
IGIM
I.G. Investment Management
Winnipeg,
Manitoba, Canada
|
-$4.35M |
MNTA Hedge Fund Activity: Q4 2013 in Review
133 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in Momenta Pharmaceuticals, Inc. (MNTA) for Q4 2013, worth a combined $730M — up 23% from $591M a quarter earlier.
Buyers outnumbered sellers: 25 funds opened new MNTA positions and 18 closed out — a net gain of 7 holders — while 39 added to existing stakes and 48 trimmed.
The largest buyer was Visium Asset Management, adding an estimated $47.4M. The largest seller was Bridger Management, exiting entirely with an estimated $24M sold.
- 133 institutional investors held Momenta Pharmaceuticals, Inc. (MNTA) as of Q4 2013, up from 126 in Q3 2013.
- Funds reported $730M of Momenta Pharmaceuticals, Inc. stock for Q4 2013, up 23% quarter-over-quarter.
- 25 funds opened new Momenta Pharmaceuticals, Inc. positions in Q4 2013 and 18 closed out, a net change of +7 holders.
- The largest Momenta Pharmaceuticals, Inc. buyer in Q4 2013 was Visium Asset Management, an estimated $47.4M added.
- The largest Momenta Pharmaceuticals, Inc. seller in Q4 2013 was Bridger Management, an estimated $24M sold.
Based on aggregated 13F filings for Q4 2013.